Maternal vaccines have the potential to reduce the global burden of neonatal morbidity and
mortality by accessing the infant immune system before a vaccine administered in childhood …

Cytotoxic T lymphocyte–associated antigen 4 (CTLA-4) is a key negative regulator of T cell
activation and proliferation. Ipilimumab is a human monoclonal antibody that specifically …

Routine vaccination has been severely impacted by the COVID-19 pandemic, with 37% of
countries reporting continuing disruptions to vaccination services into 2021. These programs …

In the United States, routine vaccination rates have plummeted across all age groups due to
the COVID-19 pandemic, with our most vulnerable and under-served populations suffering …

OBJECTIVES: Reducing and eliminating vaccine-preventable diseases requires evidence-based
and informed policy decision making. Critical to determining the functionality of the …

Success of the Global Vaccine Action Plan and improvements in vaccination coverage rates
at the sub-national, national, and global levels requires optimizing the private sector’s …

Umbilical cord blood (UCB) is an alternative stem cell source for patients without related or
unrelated donors. Single-unit UCB transplantation in adults is associated with high transplant-…

Conclusion As the case study demonstrates, a healthy market necessitates a comprehensive,
end-to-end approach including:(i) regulatory harmonization and streamlining to improve …

Introduction ‘Shocks’ or external stressors to vaccination programmes can lead to decreased
vaccination coverage rates. The capacity of vaccination ecosystems to effectively respond …

Objectives Identifying whether a country is ready to deploy a new vaccine or improve uptake
of an existing vaccine requires knowledge of a diverse range of interdependent, context-…